News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
The Iran war is already having a significant impact on prices.
The stock market is perking up a little in afternoon trading. The S&P 500 was down 0.6%; it had marked a loss as large as a percent earlier. The tech-heavy Nasdaq was extending its losses, down 1.4%. The Dow was flat.
Everything seems to be going well on Wall Street—but consumer stocks aren’t joining the party. Corporate earnings are booming, on pace for another quarter of double-digit percentage gains as the reporting season draws to a close. The State Street Consumer Discretionary Select Sector SPDR exchange-traded fund is down more than 1% since the start of the year—compared with gains of more than 8% and 15% for the S&P 500 and the Nasdaq, respectively.
Software firm Strategy (formerly MicroStrategy) and its co-founder Michael Saylor have become synonymous with Bitcoin. Here’s what you need to know.
US equity indexes fell in Tuesday's midday trading as a hotter-than-expected inflation print for Apr
We can see clearly how disruptions in the Strait of Hormuz have affected energy prices: +3.8% overall, +5.4% for gasoline.
The "Big Short" investor Michael Burry raised concerns about the current state of the market (^DJI, ^IXIC, ^GSPC), writing that it has "jumped the shark" in a Substack post on Monday. Burry is best known for predicting the 2007 mortgage crisis. Yahoo Finance Executive Editor Brian Sozzi speaks with Senior Reporter Ines Ferré and B. Riley Wealth chief market strategist Art Hogan about the factors that may set this current market apart from the dot-com bubble era.
By Ragini Mathur and Utkarsh Hathi May 12 (Reuters) - Wall Street's main indexes edged lower on Tuesday, with the S&P 500 and the Nasdaq pulling back from record highs after a hotter-than-expected
After opening little changed, the Dow slid further away from the widely watched 50,000 level. The blue-chip index was down 250 points, or 0.5%. The S&P 500 was down 0.5%, while the Nasdaq was down 0.8%.
May 12 (Reuters) - The S&P 500 and the Nasdaq opened lower on Tuesday, as investors weighed a hotter-than-expected inflation report and fading hopes for a swift resolution to the Middle East conflict.
Stocks stumbled Tuesday, with tech stocks taking a relatively bigger hit, after the latest inflation report came in hotter than expected. The Dow was flat, while the S&P 500 was down 0.4%. The tech-heavy Nasdaq was down 0.8%.
Wall Street closed slightly higher on Monday, driven by energy and industrial stocks.
Tech futures fell as oil prices topped $100 while South Korea news triggered losses in Q1 stocks. CPI inflation picked up.
Major stock indexes are settling in after a bit of volatility this morning. Dow futures have turned slightly positive, while S&P 500 futures are down 0.2%. Nasdaq futures are down 0.6%. Each of these indexes is in a place better than where they were immediately after the inflation report came out.
Consumer prices jumped more than expected in April, a sign that inflation is accelerating as the Iran war's fallout ripples through the economy. The headline consumer price index rose 0.6% from the previous month and 3.8% from a year earlier, above the 0.59% monthly gain and 3.7% annual increase economists had forecast, according to a survey by FactSet. The 3.8% annual increase marks the fastest pace of price growth since May 2023 and is also a notable jump from March, when CPI rose 3.3% year over year.
Stocks continued their downward drift after April inflation data came in higher than expected. S&P 500 futures declined 0.5%, and contracts tied to the tech-heavy Nasdaq 100 dropped nearly 1% right after the report.
International Biotechnology Trust (LSE:IBT) co-lead fund managers Ailsa Craig and Marek Poszepczynski tell Proactive's Stephen gunnion that the trust delivered NAV returns of 35.7% and share price gains of 39% in the six months to February — comfortably ahead of the Nasdaq Biotechnology Index's near-30% return. Five acquisitions completed during the period, with a further five since the interim end. Poszepczynski notes that around 40 portfolio companies have been acquired over the past five years as big pharma continues to rely on biotech for innovation. The sweetest spot for takeover activity, he says, is among companies approaching regulatory approval or commercial launch. Craig is also more optimistic on the political backdrop: "It really does feel like these political headwinds are now behind us," she says, pointing to easing concerns around US drug pricing reform and improving sentiment across the sector. For more interviews and market insights, visit the Proactive YouTube channel, give this video a like, subscribe to the channel and enable notifications for future content. #InternationalBiotechnologyTrust #Biotech #HealthcareInvesting #BiotechStocks #NasdaqBiotech #Pharma #BiotechInvesting #FDA #DrugDevelopment #MergersAndAcquisitions #HealthcareStocks #IPO #FundManagers #Investing #LifeSciences
Despite the recent surge in tech stocks, value is still outperforming tech and growth stocks in 2026.
Pre-Market Stock Futures: The futures are trading lower on Tuesday, but another week and another set of new highs for the S&P 500 and the Nasdaq, as AI fever overshadowed Iran’s peace counteroffer dismissal on Monday. The stock market opened lower on the rejection of President Trump’s peace offering, but buyers once again circled the ... Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe’s, Matador Resources, Toast and More
8.45am: US CPI rises to three-year high US inflation last month was the highest in three years, due to rising energy, housing and food prices. The US consumer price index was up 3.8% year on year in April, up from 3.26% the month before. Month-on-month, CPI increased 0.6%, easing from...
Although SpaceX IPO buzz is off the charts, history suggests an unpleasant surprise awaits retail investors.